Repligen Corporation · NASDAQ:RGEN
Loeillot Olivier sold 5,535 Repligen Corporation shares (Form 4)
Traded Oct 5, 2026 · Filed Oct 6, 2026
On Oct 5, 2026, Loeillot Olivier (Director, Chief Executive Officer) sold 5,535 Repligen Corporation shares at an average US$187.29 for US$1.04M under a trading plan, leaving 45,788 shares. Filed Oct 6, 2026 (Form 4).
- Sold
- 5,535 shares
- Price
- US$187.29 average (US$178.75 to US$190.00)
- Value
- US$1.04M
- Holding after
- 45,788 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 5, 2026 | Common Stock | Sale | 1,333 | US$178.75 | 45,788 | Direct |
| Oct 5, 2026 | Common Stock | Option exercise | 4,202 | US$154.96 | 49,990 | Direct |
| Oct 5, 2026 | Common Stock | Sale | 4,202 | US$190.00 | 45,788 | Direct |
Source
Related
- Repligen Corporation
- Loeillot Olivier
- Repligen Corporation shareholders
- Form 4 · Loeillot Olivier · Oct 5, 2026
- Form 4 · Loeillot Olivier · Sep 25, 2026
- Form 4 · Loeillot Olivier · Sep 22, 2026
- Form 4 · Loeillot Olivier · Sep 8, 2026
- Form 4 · Loeillot Olivier · Aug 21, 2026
- Form 4 · Douglass Brian Robb · Oct 8, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Garland Jason K · Sep 28, 2026
- Form 4 · Hughes Violetta · Sep 2, 2026
- Schedule 13G/A · T. Rowe Price Associates Inc · Aug 14, 2026